Ado-Trastuzumab Emtansine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ado-Trastuzumab Emtansine, covering 2022-07-20 to 2022-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer [NA]